Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

148.70 -1.22 (-0.81%)
Streaming Delayed Price Updated: 12:12 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
92 93 Next >
Balancing Dividends and Fundamentals: The Case of NYSE:JNJ.
Why JOHNSON & JOHNSON (NYSE:JNJ) is a Top Pick for Dividend Investors. 
Via Chartmill
7 blue chip stocks to Buy on the Dip: April 2024
Each of these seven blue-chip stocks to buy on the dip offer high-quality at a more-than-reasonable price. 
Via InvestorPlace
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. 
Via InvestorPlace
Johnson & Johnson Stocks Elliott Wave Technical Analysis
Looking for support as we touched 0.618 Z vs. X. If we find resistance on Medium Level at 150 then we can expected further downside. 
Via Talk Markets
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco. 
Via InvestorPlace
Unpacking the Latest Options Trading Trends in Johnson & Johnson
Via Benzinga
These Are the 10 High-Profile Stocks U.S. Politicians Have Gravitated to Most Over the Last 3 Years
These stocks kept members of Congress especially busy. 
Via The Motley Fool
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
Buying great stocks when they're on sale is a lucrative long-term strategy. 
Via The Motley Fool
Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red
These stocks are underwater right now and likely to remain so as the companies behind them manage serious problems. 
Via InvestorPlace
No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
The company is establishing its line-up of drugs behind bread-and-butter med Ingrezza. 
Via Investor's Business Daily
3 Dividend Stocks to Buy Now for Lifelong Income
Here are three dividend stocks to buy now offering stability, growth, and lifelong income in the pharmaceutical and tobacco industries. 
Via InvestorPlace
5 Crash-Proof Stocks to Buy Immediately
We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks. 
Via InvestorPlace
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more. 
Via InvestorPlace
Investing for the Long-Term: 3 Stocks With Proven Track Records
As uncertainty in the global economy and geopolitical climate abounds, investors should focus on stocks with proven track records. 
Via InvestorPlace
Topics Economy
Exposures Economy
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game. 
Via InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
The Nasdaq and S&P 500 tumbled below their 50-day lines. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages since 2020. Learn about challenges in medicine supplies, regulatory... 
Via Benzinga
Topics Brexit
Exposures Brexit
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel 
Via Benzinga
Exposures Product Safety
Top Stock Reports For Nvidia, Alphabet And Johnson & Johnson
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ). 
Via Talk Markets
Recession-Proof Riches: 3 Stocks That Thrive in Any Economy
Discover recession-proof stocks that thrive amid economic uncertainty, offering stability and consistent growth. 
Via InvestorPlace
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder. 
Via InvestorPlace
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about stock's future, highlighting potential growth from new drug approvals. JNJ aims... 
Via Benzinga
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. 
Via Benzinga
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
Although monetary policy seemed to be moving in a dovish direction, a pivot may warrant a look at stocks for Fed hikes. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Put $10,000 in These 3 Dividend Stocks by 2025
In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income. 
Via InvestorPlace
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why Johnson & Johnson Stock Got Tossed by the Market Today
A mixed quarter and narrowed guidance didn't really please investors. 
Via The Motley Fool
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
JNJ earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. and key allies explore further sanctions against Tehran. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
92 93 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.